OBJECTIVE: Preoperative use of clopidogrel increases the risk of bleeding, but its
postoperative use has not been studied. We studied early postoperative clopidogrel use in …

BACKGROUND: There is evidence that clopidogrel (with or without aspirin) confers superior
outcomes in patients with coronary artery disease. The purpose of this study is to review the …

Clopidogrel is recommended with aspirin for patients who undergo coronary artery bypass
grafting (CABG) after non–ST elevation myocardial infarctions. Cardiothoracic surgeons …

Dual antiplatelet therapy with both aspirin and clopidogrel is increasingly used after
coronary artery bypass grafting (CABG); however, little is known about the safety or efficacy …

Clopidogrel use prior to coronary artery bypass graft surgery in patients presenting with
acute coronary syndromes is associated with a greater incidence of procedural related …

BACKGROUND: Patients who undergo off-pump coronary artery bypass graft surgery
(OPCAB) may be hypercoagulable with an increased risk of graft thrombosis due to the lack …

OBJECTIVES Recent guidelines suggest that patients undergoing coronary artery bypass
grafting (CABG) should discontinue clopidogrel and aspirin (ASA) 5 and 2–10 days …

Objective The purpose of this randomized study was to evaluate the effect on graft patency
by adding clopidogrel to aspirin in off-pump coronary artery bypass (OPCAB) grafting and …

Objectives: The goal of this study was to assess the safety of early postoperative clopidogrel
in patients undergoing on‐pump and off‐pump coronary artery bypass graft (CABG) surgery …

Background: Antiplatelet therapy is critical in the management of coronary artery disease.
For patients undergoing coronary artery bypass graft surgery (CABG), controversy remains …